1984
DOI: 10.1111/j.1365-2125.1984.tb02521.x
|View full text |Cite
|
Sign up to set email alerts
|

Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease [letter]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
2006
2006

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…Oral dosing commenced immediately on cessation of the intrave¬ nous aminophylline will enable therapeutic theophylline levels to be maintained without the need for tapering or overlap. 81 Theophylline dose should be slowly titrated upward in stable outpatients with COPD, using clinical indexes and occasional blood levels to guide therapy. To minimize the risk of toxicity, initial daily doses should not exceed 400 mg in nonsmoking adults82 or 600 mg in smokers.…”
Section: Intravenous Administrationmentioning
confidence: 99%
“…Oral dosing commenced immediately on cessation of the intrave¬ nous aminophylline will enable therapeutic theophylline levels to be maintained without the need for tapering or overlap. 81 Theophylline dose should be slowly titrated upward in stable outpatients with COPD, using clinical indexes and occasional blood levels to guide therapy. To minimize the risk of toxicity, initial daily doses should not exceed 400 mg in nonsmoking adults82 or 600 mg in smokers.…”
Section: Intravenous Administrationmentioning
confidence: 99%